Midd-term effects of trabeculectomy with mitomycin C in neovascular glaucoma patients.

Published on Dec 1, 2001in Korean Journal of Ophthalmology
· DOI :10.3341/KJO.2001.15.2.98
Sung Min Hyung4
Estimated H-index: 4
(CBNU: Chungbuk National University),
Sang Kook Kim2
Estimated H-index: 2
(CBNU: Chungbuk National University)
Sources
Abstract
: Twenty four eyes from 23 neovascular glaucoma (NVG) patients, who underwent trabeculectomy with 0.2 or 0.4 mg/ml MMC in least the previous 6 months, were examined in order to evaluate the mid-term effects of a trabeculectomy with mitomycin C (MMC) in NVG. Success defined when an intraocular pressure (IOP) 5 mmHg with or without medication was observed. The mean IOP was reduced from 46.8+/-12.9 mmHg preoperatively to 18.2+/-12.0 mmHg at the last follow-up (mean = 25.8 months). The overall success rates at 1-, 3-, 6-, 9-, and 12-months after surgery were 71%, 58%, 50%, 29%, 29% respectively. The number of anti-glaucoma medications administered was significantly reduced from 2.6+/-0.7 preoperatively to 0.9+/-1.0 postoperatively (Wilcoxon signed rank test, p = 0.005). In addition both the intraoperative MMC concentration and application time had no influence on lowering the IOP (logistic regression analysis, p = 0.228, 0.910, respectively). There was a similar incidence of postoperative complications in both the success and failure group. These results suggest that a trabeculectomy with MMC is an effective surgical procedure in NVG patients and the MMC concentration is not crucial for reducing the IOP postoperatively.
📖 Papers frequently viewed together
184 Citations
5 Authors (Yoshiaki Kiuchi, ..., Shigeo Ito)
42 Citations
69 Citations
References0
Newest
Cited By25
Newest
#1Kana Tokumo (Hiroshima University)H-Index: 4
#2Kaori Komatsu (Hiroshima University)H-Index: 1
Last. Yoshiaki Kiuchi (Hiroshima University)H-Index: 24
view all 9 authors...
PURPOSE To compare surgical outcomes between patients who underwent Baerveldt glaucoma implantation versus trabeculectomy (TLE) for the treatment of neovascular glaucoma. METHODS We performed a prospective, randomized, controlled clinical trial at Hiroshima University and Tsukazaki Hospital, Japan. Patients were randomized to Baerveldt glaucoma implantation (23 patients) or TLE (27 patients). The primary outcome measure was the rate of intraocular-pressure control. Secondary outcome measures inc...
Source
The administration of postoperative bevacizumab injection in subconjunctival trabeculectomy will reduce bleb fibrosis. This study aimed to investigate the effect of bevacizumab as an antifibrotic agent on collagen density, collagen thickness and type I collagen expression after trabeculectomy in rabbits. Sixteen males New Zealand white rabbits were divided into two groups, control and treatment group. Masson’s trichrome was performed to evaluate collagen density and thickness. Immunohistochemis...
Source
#1Rajen Tailor (Leicester Royal Infirmary)H-Index: 3
#2Theodoros LaliasH-Index: 1
Neovascular glaucoma carries a poor visual prognosis and surgery is frequently required to control the intraocular pressure. For patients who have visual potential, conventional glaucoma surgery such as a glaucoma drainage device or trabeculectomy are frequently performed. Cyclophotocoagulation is often reserved for eyes with poor visual potential, blind eyes, or where for medical reasons it is not possible for patients to have conventional surgery. Furthermore, patients with neovascular glaucom...
5 CitationsSource
#1Rajen Tailor (UCL Institute of Ophthalmology)H-Index: 2
#2Matt T. Kinsella (UCL Institute of Ophthalmology)H-Index: 1
Last. Jonathan Clarke (UCL Institute of Ophthalmology)H-Index: 4
view all 3 authors...
ABSTRACTBackground: To report the outcome of intravitreal Bevacizumab followed by Ahmed valve implantation in the management of neovascular glaucoma in a patient group with extended follow-up. Methods: The records of 16 patients (18 eyes) with neovascular glaucoma refractory to medical therapy who presented to a single surgeon between 2006–2008 were reviewed. Patients received pan-retinal photocoagulation and then intravitreal Bevacizumab followed by Ahmed valve implantation. The main outcome me...
3 CitationsSource
#1Amitabha S. Bhakta (Bascom Palmer Eye Institute)H-Index: 1
#2Jorge A. Fortun (Bascom Palmer Eye Institute)H-Index: 10
Last. Arindel S. MaharajH-Index: 1
view all 6 authors...
Purpose:This study examines the incidence of visually significant cystoid macular edema (CME) after glaucoma drainage implant (GDI) surgery and analyses risk factors associated with developing CME and prognosis with treatment.Materials and Methods:In total, 185 eyes from 185 glaucoma patients (mean
2 CitationsSource
#1Ye He (CSU: Central South University)H-Index: 4
#2Ying TianH-Index: 4
Last. Xiaobo XiaH-Index: 14
view all 6 authors...
: This study aimed to evaluate the efficacy of Ahmed glaucoma valve (AGV) implantation in treating neovascular glaucoma (NVG) and to analyze the factors influencing the surgical success rate.This is a retrospective review of 40 eyes of 40 NVG patients who underwent AGV implantation at Xiangya Hospital of Central South University, China, between January 2014 and December 2016. Pre- and postoperative intraocular pressure (IOP), visual acuity, surgical success rate, medications, and complications w...
5 CitationsSource
#1Shikha Gupta (AIIMS: All India Institute of Medical Sciences)H-Index: 12
#2Abadh K. Chaurasia (AIIMS: All India Institute of Medical Sciences)H-Index: 5
Last. Viney Gupta (AIIMS: All India Institute of Medical Sciences)H-Index: 25
view all 7 authors...
Purpose To evaluate long-term success of the Ahmed glaucoma valve (AGV) for refractory glaucoma after vitreoretinal surgery with silicone oil insertion.
10 CitationsSource
#1Tomomi Higashide (Kanazawa University)H-Index: 24
#2Shinji Ohkubo (Kanazawa University)H-Index: 19
Last. Kazuhisa Sugiyama (Kanazawa University)H-Index: 39
view all 3 authors...
Purpose To evaluate long-term outcomes and identify prognostic factors of trabeculectomy following intraocular bevacizumab injection for neovascular glaucoma.
14 CitationsSource
#1Shunji Nakatake (Kyushu University)H-Index: 11
#2Shigeo Yoshida (Kyushu University)H-Index: 6
Last. Tatsuro Ishibashi (Kyushu University)H-Index: 77
view all 9 authors...
Background Several retinal ischemic diseases can cause neovascular glaucoma (NVG). Trabeculectomy with mitomycin C (MMC) is a relatively better treatment modality in the management of eyes with NVG than other glaucoma surgeries. The aim of this study was to investigate the factors that may influence the outcome of trabeculectomy with MMC for NVG.
29 CitationsSource
To evaluate the long-term success of trabeculectomy with mitomycin C for glaucoma after vitreoretinal surgery with silicone oil insertion. Prospective evaluation of patients who underwent trabeculectomy with mitomycin C (superior or inferior site) for glaucoma after vitreoretinal surgery. Parameters examined included intraocular pressure (IOP), visual acuity, and glaucomatous neuropathy status, preoperatively and at multiple follow-up visits postoperatively till 12 months. Success, both absolute...
13 CitationsSource